CFP Weight Loss with Russell Clark

Russell Clark, FNP-C

Evidence-based weight loss education from Nurse Practitioner Russell Clark. Real answers for people over 40 navigating GLP-1s, metabolic health, and sustainable results.

  1. Oct 21

    From the 30-Week Reset Lens: Albumin and Hypothalamic Harmony

    From the 30-Week Reset Lens: Albumin and Hypothalamic Harmony Welcome to CFP Weight Loss. I'm Russell Clark, Nurse Practitioner. Today, we're exploring From the 30-Week Reset Lens: Albumin and Hypothalamic Harmony. ... I'm not here to sensationalize. We'll examine the topic through research, physiology, and practical clinical experience. ... We'll touch on 30-Week Tirzepatide Reset, Albumin Levels, Hypothalamic Function — especially as they apply to real people over forty. ... Let's start with from the 30-week reset lens: albumin and hypothalamic harmony. ... The 30-Week Tirzepatide Reset . is more than a medication cycling protocol—it is a comprehensive metabolic recalibration system. At its core lies an often-overlooked relationship between serum albumin and hypothalamic function. Albumin, the most abundant plasma protein, serves as a critical carrier for hormones, fatty acids, and micronutrients while maintaining oncotic pressure. The hypothalamus, acting as the body’s master metabolic regulator, integrates signals from leptin, insulin, GLP-1, and cortisol to control hunger, energy expenditure, and set-point defense. When these two systems fall out of harmony, weight loss stalls, cravings intensify, and metabolic flexibility declines. Listen at CFP Weight Loss — clinical guide with Russell Clark, FNP-C. Read more: https://blog.cfpweightloss.com/from-the-30-week-reset-lens-albumin-and-hypothalamic-harmony-pzn65n

  2. Oct 21

    Contrast Therapy in Tirzepatide Cycling: Maintenance Phase Mastery

    Contrast Therapy in Tirzepatide Cycling: Maintenance Phase Mastery Welcome to CFP Weight Loss. I'm Russell Clark, Nurse Practitioner. Today, we're exploring Contrast Therapy in Tirzepatide Cycling: Maintenance Phase Mastery. ... I'm going to keep this calm and practical, and stick to what the clinical evidence actually says. ... We'll touch on Contrast Therapy, Tirzepatide Cycling, Maintenance Phase — especially as they apply to real people over forty. ... Let's start with introduction. ... In the 30-Week Tirzepatide Reset , the maintenance phase (weeks 19–30) marks the transition from active fat loss to sustainable metabolic health. During this stage, structured 6-week-on, 4-week-off cycling prevents receptor desensitization while rebuilding endogenous regulation. Contrast therapy—alternating hot and cold exposure—emerges as a powerful adjunct that amplifies these benefits. By enhancing circulation, reducing inflammation, and supporting mitochondrial efficiency , contrast therapy helps preserve lean mass, stabilize insulin sensitivity, and minimize rebound during medication holidays. This integration creates a synergistic protocol that aligns pharmacological cycling with physiological stressors to lock in long-term metabolic flow. ... Listen at CFP Weight Loss — clinical guide with Russell Clark, FNP-C. Read more: https://blog.cfpweightloss.com/contrast-therapy-during-tirzepatide-cycling-for-maintenance-phase-ftfg2m

  3. Oct 21

    Root-Cause View of MCV (Joint Pain & Limited Mobility) via Non-Scale Victories Tracking

    Root-Cause View of MCV (Joint Pain & Limited Mobility) via Non-Scale Victories Tracking Welcome to CFP Weight Loss. I'm Russell Clark, Nurse Practitioner. Today, we're exploring Root-Cause View of MCV (Joint Pain & Limited Mobility) via Non-Scale Victories Tracking. ... I'm not here to sensationalize. We'll examine the topic through research, physiology, and practical clinical experience. ... We'll touch on MCV Joint Pain, Non-Scale Victories, Tirzepatide Reset — especially as they apply to real people over forty. ... Root-Cause View of MCV (Joint Pain & Limited Mobility) via Non-Scale Victories Tracking ... Metabolic Chronic Inflammation (MCV) often manifests as persistent joint pain and limited mobility long before dramatic scale changes appear. In the 30-Week Tirzepatide Reset , tracking non-scale victories (NSVs) reveals the true root causes—visceral adiposity, insulin resistance, cytokine-driven inflammation, and gut microbiome disruption—while providing early proof of physiologic repair. This root-cause lens shifts focus from pounds lost to restored function, showing how Calories In Calories Out, HOMA-IR improvement, and strategic cycling create lasting metabolic flow. ... First — understanding mcv as a root driver of joint pain and reduced mobility. ... Listen at CFP Weight Loss — clinical guide with Russell Clark, FNP-C. Read more: https://blog.cfpweightloss.com/root-cause-view-of-mcv-joint-pain-limited-mobility-via-non-scale-victories-track-mw3r2n

About

Evidence-based weight loss education from Nurse Practitioner Russell Clark. Real answers for people over 40 navigating GLP-1s, metabolic health, and sustainable results.

You Might Also Like